Name: | PULMOKINE, INC. |
Jurisdiction: | New York |
Legal type: | FOREIGN BUSINESS CORPORATION |
Status: | Active |
Date of registration: | 04 Dec 2007 (17 years ago) (Companies founded in December 2007) |
Entity Number: | 3600478 |
ZIP code: | 12159 (Companies in Albany, 12159) |
County: | Albany |
Place of Formation: | Delaware |
Address: | 68 QUEEN ANNE DR., SLINGERLANDS, NY, United States, 12159 |
Principal Address: | 68 QUEEN ANNE DRIVE, SLINGERLANDS, NY, United States, 12159 |
CAGE number | Status | Type | Established | CAGE Update Date | CAGE Expiration | SAM Expiration | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4XMX0 | Active | Non-Manufacturer | 2007-11-29 | 2024-09-21 | 2024-10-21 | No data | |||||||||||||
|
POC | SHREEFAL MEHTA |
Phone | +1 518-331-8078 |
Address | 105 JORDAN RD STE 3, TROY, RENSSELAER, NY, 12180 8376, UNITED STATES |
Ownership of Offeror Information
Highest Level Owner | Information not Available |
---|
Immediate Level Owner | Information not Available |
---|
List of Offerors (0) | Information not Available |
---|
Name | Role | Address |
---|---|---|
THE CORPORATION | DOS Process Agent | 68 QUEEN ANNE DR., SLINGERLANDS, NY, United States, 12159 |
Name | Role | Address |
---|---|---|
LAWRENCE S ZISMAN | Chief Executive Officer | 68 QUEEN ANNE DRIVE, SLINGERLANDS, NY, United States, 12159 |
Filing Number | Date Filed | Type | Effective Date |
---|---|---|---|
140605002231 | 2014-06-05 | BIENNIAL STATEMENT | 2013-12-01 |
120117003037 | 2012-01-17 | BIENNIAL STATEMENT | 2011-12-01 |
091222002333 | 2009-12-22 | BIENNIAL STATEMENT | 2009-12-01 |
071204000057 | 2007-12-04 | APPLICATION OF AUTHORITY | 2007-12-04 |
Contract Type | Award or IDV Flag | PIID | Start Date | Current End Date | Potential End Date | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DEFINITIVE CONTRACT | AWARD | HHSN268201400013C | 2013-11-14 | 2016-11-14 | 2016-11-14 | |||||||||||||||||||||||||
|
Obligated Amount | 1549476.97 |
Current Award Amount | 1549476.97 |
Potential Award Amount | 1549476.97 |
Description
Title | VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): IND ENABLING STUDIES FOR A NOVEL INHALED PDGF RECEPTOR INHIBITOR TO TREAT PAH |
NAICS Code | 541712: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) |
Product and Service Codes | AN12: HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
Recipient Details
Recipient | PULMOKINE, INC. |
UEI | CJAVXCPZUUM9 |
Recipient Address | UNITED STATES, 68 QUEEN ANNE DR, SLINGERLANDS, ALBANY, NEW YORK, 121599385 |
Date of last update: 09 Nov 2024
Sources: New York Secretary of State